XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Licensing revenue $ 125,000
Operating expenses:    
Research and development 2,619,805 3,095,420
General and administrative 3,064,645 2,871,557
Total operating expenses 5,684,450 5,966,977
Loss from operations (5,684,450) (5,841,977)
Other (expense) income:    
Investment income 253,070 12,104
Interest expense on preferred stock (4,551,567)
Interest expense on loan facility (159,985) (94,690)
Other income 1,798
Total other income (expense), net 93,085 (4,632,355)
Net loss $ (5,591,365) $ (10,474,332)
Net loss per common share    
Basic and diluted $ (0.68) $ (1.82)
Weighted average shares outstanding    
Basic and diluted 8,281,483 5,770,467